SINGAPORE: Researchers in Singapore have developed a breath test to detect COVID-19 within a minute, said the National University of Singapore ...
A person testing for COVID-19 would simply have to blow into a disposable mouthpiece connected to a “high-precision breath sampler”, said the university in a media release.A machine learning software subsequently analyses the VOC profile and generates the result in less than a minute.Breathonix is founded by Dr Jia Zhunan and Mr Du Fang . With them is NUS Senior Vice President Professor Freddy Boey .
VOCs are consistently produced by various biochemical reactions in human cells, explained Breathonix CEO Dr Jia Zhunan. “Our breath test is easy to administer and it does not require specially trained staff or laboratory processing,” he added.Currently, standard COVID-19 screening involves a swab test, which may be uncomfortable, and diagnosis using polymerase chain reaction tests can take a few hours.
The test, which uses in-built machine learning algorithms, achieved more than 90 per cent accuracy, with 93 per cent sensitivity.The clinical trial is ongoing and more tests are required to further improve the accuracy of the technology, said NUS.
Nigeria Latest News, Nigeria Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
China reports 19 new COVID-19 casesSHANGHAI: China reported 19 new coronavirus cases in the mainland for Monday (Oct 19) up from 13 cases a day earlier, the health commission said ...
Read more »
7 new COVID-19 cases in Singapore, including 1 in communitySINGAPORE: Singapore reported seven new COVID-19 cases as of noon on Sunday (Oct 18), bringing the national total to 57,911. Of the new ...
Read more »
Seven new Covid-19 cases in Singapore, including one community case[SINGAPORE] There were seven new coronavirus cases confirmed as at Sunday noon, taking Singapore's total to 57,911. Read more at The Business Times.
Read more »
COVID-19: 7 new cases detected in SingaporeMOH confirmed the detection of seven new cases of COVID-19 infection in Singapore as of noon on Sunday (18 October).
Read more »
Singapore pauses enrolment for Covid-19 antibody trial after halting of US drugmaker's trialSINGAPORE - The National Centre for Infectious Diseases (NCID) has temporarily stopped enrolling Covid-19 patients for a monoclonal antibody trial after the American pharmaceutical company that developed the drug had to halt the trial due to safety concerns last week.. Read more at straitstimes.com.
Read more »